Alpha DNA Investment Management’s Builders FirstSource BLDR Stock Holding History

Alpha DNA Investment Management’s Portfolio BLDR Stock Details BLDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,739	Closed	-$391K	–	32
2024 Q4	$391K	Buy	2,739 +187	+7%	+$33.1K	0.15%	177
2024 Q3	$495K	Buy	2,552 +293	+13%	+$48.6K	0.19%	116
2024 Q2	$313K	Buy	2,259 +526	+30%	+$89.3K	0.12%	191
2024 Q1	$361K	Sell	1,733 -718	-29%	-$133K	0.13%	176
2023 Q4	$409K	Sell	2,451 -3,684	-60%	-$490K	0.16%	152
2023 Q3	$764K	Buy	+6,135	New	+$846K	0.31%	72
2022 Q2	–	Sell	-17,928	Closed	-$1.16M	–	123
2022 Q1	$1.16M	Buy	+17,928	New	+$1.3M	0.81%	87
2021 Q2	–	Sell	-65	Closed	-$3K	–	160
2021 Q1	$3K	Buy	+65	New	+$2.77K	﹤0.01%	451

Other funds holding BLDR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Alpha DNA Investment Management's BLDR Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Builders FirstSource (BLDR) in Q1 2025, closing a stake of 2,739 shares — an estimated $391K sold.

Alpha DNA Investment Management first reported a position in BLDR in Q1 2021 and held it in 8 quarters. The position peaked at $1.16M in Q1 2022. 785 funds tracked by Wall St. Rank hold BLDR as of Q1 2025.

Alpha DNA Investment Management reported no remaining Builders FirstSource position as of Q1 2025 after selling out during the quarter.
Alpha DNA Investment Management sold 2,739 Builders FirstSource shares in Q1 2025, an estimated $391K.
Alpha DNA Investment Management first reported a position in Builders FirstSource in Q1 2021 and held it in 8 quarters.
Alpha DNA Investment Management's Builders FirstSource position peaked at $1.16M in Q1 2022.
785 funds tracked by Wall St. Rank held Builders FirstSource as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.